[1] |
Ting WH, Lin HH, Hsiao SM. Factors predicting persistent ectopic pregnancy after laparoscopic salpingostomy or salpingotomy for tubal pregnancy: a retrospective cohort study [J]. J Minim Invasive Gynecol, 2019, 26(6): 1036-1043. DOI: 10.1016/j.jmig.2018.10.004.
|
[2] |
Seifer DB, Diamond MP, DeCherney AH. Persistent ectopic pregnancy [J]. Obstet Gynecol Clin North Am, 1991, 18(1): 153-159.
|
[3] |
Spandorfer SD, Sawin SW, Benjamin I, et al. Postoperative day 1 serum human chorionic gonadotropin level as a predictor of persistent ectopic pregnancy after conservative surgical management [J]. Fertil Steril, 1997, 68(3): 430-434. DOI: 10.1016/s0015-0282(97)00253-7.
|
[5] |
Hsu MI, Tang CH, Hsu PY, et al. Primary and repeated surgeries for ectopic pregnancies and distribution by patient age, surgeon age, and hospital levels: an 11-year nationwide population-based descriptive study in Taiwan [J]. J Minim Invasive Gynecol, 2012, 19(5): 598-605. DOI: 10.1016/j.jmig.2012.05.008.
|
[4] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
Zhang Y, Chen J, Lu W, et al. Clinical characteristics of persistent ectopic pregnancy after salpingostomy and influence on ongoing pregnancy [J]. J Obstet Gynaecol Res, 2017, 43(3): 564-570. DOI: 10.1111/jog.13251.
|
[10] |
Poppe WA, Vandenbussche N. Postoperative day 3 serum human chorionic gonadotropin decline as a predictor of persistent ectopic pregnancy after linear salpingotomy [J]. Eur J Obstet Gynecol Reprod Biol, 2001, 99(2): 249-252. DOI: 10.1016/s0301-2115(01)00397-9.
|
[11] |
Kayatas S, Demirci O, Kumru P, et al. Predictive factors for failure of salpingostomy in ectopic pregnancy [J]. J Obstet Gynaecol Res, 2014, 40(2): 453-458. DOI: 10.1111/jog.12187.
|
[12] |
Seifer DB, Gutmann JN, Doyle MB, et al. Persistent ectopic pregnancy following laparoscopic linear salpingostomy [J]. Obstet Gynecol, 1990, 76(6): 1121-1125.
|
[13] |
Billieux MH, Petignat P, Anguenot JL, et al. Early and late half-life of human chorionic gonadotropin as a predictor of persistent trophoblast after laparoscopic conservative surgery for tubal pregnancy [J]. Acta Obstet Gynecol Scand, 2003, 82(6): 550-555. DOI: 10.1034/j.1600-0412.2003.00154.x.
|
[14] |
|
[15] |
Mol F, van Mello NM, Strandell A, et al. Salpingotomy versus salpingectomy in women with tubal pregnancy (ESEP study): an open-label, multicentre, randomised controlled trial [J]. Lancet, 2014, 383(9927): 1483-1489. DOI: 10.1016/S0140-6736(14)60123-9.
|
[16] |
Lagana AS, Vitale SG, De Dominici R, et al. Fertility outcome after laparoscopic salpingostomy or salpingectomy for tubal ectopic pregnancy A 12-years retrospective cohort study [J]. Ann Ital Chir, 2016, 87: 461-465.
|
[17] |
Cheng X, Tian X, Yan Z, et al. Comparison of the fertility outcome of salpingotomy and salpingectomy in women with tubal pregnancy: a systematic review and Meta-analysis [J]. PLoS One, 2016, 11(3): e152343. DOI: 10.1371/journal.pone.0152343.
|
[18] |
Abe T, Akira S, Negishi Y, et al. Relevance of declines in serum human chorionic gonadotropin levels to the management of persistent ectopic pregnancy [J]. J Obstet Gynaecol Res, 2009, 35(5): 961-966. DOI: 10.1371/journal.pone.0152343.
|
[19] |
Morse AN, Si W, Qin S, et al. Optimal use of peri-operative human chorionic gonadotrophin concentrations to identify persistent ectopic pregnancy after laparoscopic salpingostomy: a retrospective cohort study[J]. Reprod Biomed Online, 2018, 36(3): 361-368. DOI: 10.1016/j.rbmo.2017.12.006.
|
[20] |
Akira S, Negishi Y, Abe T, et al. Prophylactic intratubal injection of methotrexate after linear salpingostomy for prevention of persistent ectopic pregnancy[J]. J Obstet Gynaecol Res, 2008, 34(5): 885-889. DOI: 10.1111/j.1447-0756.2008.00746.x.
|
[21] |
Graczykowski JW, Mishell J. Methotrexate prophylaxis for persistent ectopic pregnancy after conservative treatment by salpingostomy [J]. Obstet Gynecol, 1997, 89(1): 118-122. DOI: 10.1016/s0029-7844(96)00370-5.
|
[22] |
|